A single view of all the companies in the same space to infer if the stock is undervalued, overvalued or priced right. This would be one way to analyze a longer terms investment in a particular sector.
| Company | Market Cap | Income | Sales | P/E | P/B | Cash/Share | Dividend | Dividend Yield | Price To Cash Ratio | Debt to Equity Ratio | ROE | ROA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
| Abeona Therapeutics Inc. | 27,210,000 | -54,100,000 | 3,000,000 | 0.00 | 0.30 | 0.61 | - | - | 0.41 | 0.00 | -60.00% | -39.90% |
| Absci Corporation | 828,720,000 | -83,800,000 | 6,100,000 | 0.00 | 1.73 | 3.08 | - | - | 2.97 | 0.03 | - | - |
| Adagio Therapeutics, Inc. | 816,620,000 | -191,800,000 | 0 | 0.00 | 0.68 | 5.71 | - | - | 1.23 | 0.00 | - | - |
| Aditxt, Inc. | 17,120,000 | -27,000,000 | 0 | 0.00 | 0.55 | 0.13 | - | - | 3.11 | 0.00 | -261.40% | -162.20% |
| Aeterna Zentaris Inc. | 48,580,000 | -6,500,000 | 4,200,000 | 0.00 | 0.82 | 0.57 | - | - | 0.71 | 0.00 | -13.10% | -8.90% |
| AgeX Therapeutics, Inc. | 29,800,000 | -8,900,000 | 600,000 | 0.00 | 0.00 | 0.02 | - | - | 42.58 | 0.00 | 122.10% | -297.50% |
| AIkido Pharma Inc. | 41,300,000 | -5,000,000 | 0 | 0.00 | 0.39 | 1.05 | - | - | 0.42 | 0.00 | -5.90% | -5.80% |
| AIM ImmunoTech Inc. | 41,680,000 | -17,200,000 | 100,000 | 0.00 | 0.69 | 0.80 | - | - | 1.10 | 0.00 | -26.20% | -25.10% |
| Allarity Therapeutics, Inc. | 62,730,000 | 0 | -7,130,000 | 0.00 | 25.24 | 0.72 | - | - | 11.00 | 0.00 | - | - |
| Allena Pharmaceuticals, Inc. | 36,340,000 | -48,600,000 | 0 | 0.00 | 1.22 | 0.46 | - | - | 0.90 | 0.00 | -230.20% | -126.50% |
| Aileron Therapeutics, Inc. | 39,900,000 | -24,400,000 | 0 | 0.00 | 0.78 | 0.56 | - | - | 0.76 | 0.00 | -54.20% | -49.60% |
| Ampio Pharmaceuticals, Inc. | 112,610,000 | -15,500,000 | 0 | 0.00 | 5.62 | 0.08 | - | - | 6.59 | 0.00 | -86.00% | -66.00% |
| Ardelyx, Inc. | 79,710,000 | -150,800,000 | 10,900,000 | 0.00 | 0.87 | 1.21 | - | - | 0.56 | 0.63 | -132.30% | -76.60% |
| Artelo Biosciences, Inc. | 17,820,000 | -8,600,000 | 0 | 0.00 | 0.42 | 0.54 | - | - | 0.72 | 0.00 | -52.50% | -50.70% |
| Alterity Therapeutics Limited | 36,300,000 | -11,000,000 | 4,340,000 | 0.00 | 1.49 | 0.00 | - | - | 0.00 | 0.00 | -73.60% | -64.20% |
| Athersys, Inc. | 228,880,000 | -87,500,000 | 6,100,000 | 0.00 | 7.09 | 0.20 | - | - | 4.61 | 0.00 | -268.20% | -126.10% |
| Avenue Therapeutics, Inc. | 11,300,000 | -3,800,000 | 0 | 0.00 | 0.00 | 0.03 | - | - | 18.83 | 0.00 | -353.20% | -215.70% |
| Aura Biosciences, Inc. | 520,530,000 | 0 | 0 | 0.00 | 0.00 | 0.00 | - | - | 0.00 | 0.00 | - | - |
| Avalo Therapeutics, Inc. | 105,930,000 | -81,400,000 | 6,700,000 | 0.00 | 2.20 | 0.00 | - | - | 0.00 | 0.81 | -270.30% | -121.30% |
| Brickell Biotech, Inc. | 28,140,000 | -40,800,000 | 300,000 | 0.00 | 0.98 | 0.00 | - | - | 0.00 | 0.00 | -165.40% | -129.70% |
| Bionomics Limited | 79,520,000 | 0 | 930,000 | 0.00 | 11.63 | 0.00 | - | - | 0.00 | 0.00 | - | - |
| Baudax Bio, Inc. | 15,880,000 | -66,200,000 | 800,000 | 0.00 | 0.00 | 0.27 | - | - | 0.64 | 0.00 | 644.80% | -95.00% |
| Candel Therapeutics, Inc. | 123,090,000 | 0 | 120,000 | 0.00 | 1.48 | 2.87 | - | - | 1.39 | 0.01 | - | - |
| Calithera Biosciences, Inc. | 36,900,000 | -68,400,000 | 9,800,000 | 0.00 | 0.50 | 1.13 | - | - | 0.44 | 0.00 | -77.30% | -64.60% |
| CASI Pharmaceuticals, Inc. | 103,130,000 | -45,300,000 | 25,800,000 | 0.00 | 1.18 | 0.44 | - | - | 1.65 | 0.01 | -49.90% | -32.50% |
| Catalyst Biosciences, Inc. | 17,610,000 | -86,500,000 | 6,900,000 | 0.00 | 0.27 | 1.91 | - | - | 0.27 | 0.00 | -106.10% | -87.80% |
| C4 Therapeutics, Inc. | 1,160,000,000 | -79,700,000 | 34,000,000 | 0.00 | 2.88 | 8.22 | - | - | 2.88 | 0.03 | -23.40% | -17.60% |
| ChemoCentryx, Inc. | 2,100,000,000 | -121,100,000 | 34,300,000 | 0.00 | 6.59 | 3.82 | - | - | 7.80 | 0.07 | -34.80% | -25.00% |
| Avid Bioservices, Inc. | 1,330,000,000 | 8,300,000 | 106,300,000 | 164.50 | 25.57 | 2.62 | - | - | 8.10 | 2.77 | 12.80% | 3.30% |
| Cidara Therapeutics, Inc. | 55,500,000 | -47,300,000 | 46,100,000 | 0.00 | 0.00 | 0.53 | - | - | 1.52 | 0.00 | -694.60% | -82.40% |
| Codexis, Inc. | 1,320,000,000 | -15,000,000 | 101,300,000 | 0.00 | 7.48 | 1.77 | - | - | 11.10 | 0.00 | -9.00% | -6.90% |
| Creative Medical Technology Holdings, Inc. | 11,010,000 | -15,500,000 | 40,000 | 0.00 | 0.00 | 0.34 | - | - | 4.59 | 0.00 | 140.40% | - |
| Cerevel Therapeutics Holdings, Inc. | 4,350,000,000 | -311,400,000 | 0 | 0.00 | 7.01 | 4.72 | - | - | 6.49 | 0.00 | -75.60% | -63.00% |
| Cullinan Oncology, Inc. | 617,710,000 | -61,400,000 | 18,900,000 | 0.00 | 1.33 | 7.07 | - | - | 1.92 | 0.00 | -19.10% | -15.20% |
| Compugen Ltd. | 262,700,000 | -34,100,000 | 8,000,000 | 0.00 | 2.64 | 0.00 | - | - | 0.00 | 0.00 | -31.50% | -26.60% |
| Cognition Therapeutics, Inc. | 94,320,000 | 0 | 0 | 0.00 | 0.00 | 0.35 | - | - | 11.36 | 0.00 | - | - |
| CinCor Pharma, Inc. | 913,060,000 | -26,800,000 | 0 | 0.00 | 0.00 | 3.77 | - | - | 6.44 | 0.00 | - | - |
| Checkpoint Therapeutics, Inc. | 190,210,000 | -37,100,000 | 300,000 | 0.00 | 3.54 | 0.68 | - | - | 3.16 | 0.00 | -76.40% | -64.30% |
| Caladrius Biosciences, Inc. | 47,000,000 | -26,100,000 | 0 | 0.00 | 0.45 | 1.60 | - | - | 0.47 | 0.00 | -30.10% | -28.90% |
| Celldex Therapeutics, Inc. | 1,480,000,000 | -72,300,000 | 8,100,000 | 0.00 | 3.29 | 9.03 | - | - | 3.50 | 0.00 | -28.30% | -25.80% |
| Cellectis S.A. | 267,519,999 | -127,800,000 | 70,100,000 | 0.00 | 1.02 | 0.00 | - | - | 0.00 | 0.44 | -38.50% | -22.70% |
| Clene Inc. | 174,500,000 | -13,400,000 | 600,000 | 0.00 | 29.89 | 0.93 | - | - | 2.88 | 3.42 | - | - |
| Cellectar Biosciences, Inc. | 36,500,000 | -21,800,000 | 0 | 0.00 | 0.92 | 0.63 | - | - | 0.91 | 0.00 | -60.10% | -42.90% |
| Clearside Biomedical, Inc. | 102,290,000 | -25,400,000 | 3,900,000 | 0.00 | 5.70 | 0.42 | - | - | 4.06 | 0.00 | -161.70% | -98.70% |
| Celsion Corporation | 37,000,000 | -19,600,000 | 500,000 | 0.00 | 0.59 | 0.60 | - | - | 0.68 | 0.10 | -39.70% | -28.70% |
| Clovis Oncology, Inc. | 253,500,000 | -299,100,000 | 156,100,000 | 0.00 | 0.00 | 0.00 | - | - | 0.00 | 0.00 | 147.30% | -53.50% |
| Chemomab Therapeutics Ltd. | 53,200,000 | -9,600,000 | 0 | 0.00 | 0.05 | 3.08 | - | - | 1.41 | 0.00 | -19.20% | -18.20% |
| Chimerix, Inc. | 514,220,000 | -145,400,000 | 3,100,000 | 0.00 | 4.75 | 1.37 | - | - | 4.19 | 0.13 | -135.00% | -111.10% |
| Concert Pharmaceuticals, Inc. | 113,000,000 | -66,300,000 | 32,600,000 | 0.00 | 1.09 | 2.97 | - | - | 1.06 | 0.00 | -56.80% | -46.00% |
| CNS Pharmaceuticals, Inc. | 10,900,000 | -14,200,000 | 0 | 0.00 | 1.08 | 0.27 | - | - | 1.31 | 0.00 | -122.00% | -104.10% |
| Centessa Pharmaceuticals Limited | 959,180,000 | -559,800,000 | 0 | 0.00 | 1.56 | 5.74 | - | - | 1.66 | 0.00 | - | - |
| Connect Biopharma Holdings Limited | 256,950,000 | 0 | 0 | 0.00 | 0.11 | 0.00 | - | - | 0.00 | 0.00 | - | - |
| Context Therapeutics Inc. | 22,990,000 | -8,100,000 | 0 | 0.00 | 0.00 | 0.03 | - | - | 57.48 | 0.00 | - | - |
| Cocrystal Pharma, Inc. | 54,990,000 | -12,000,000 | 500,000 | 0.00 | 0.67 | 0.62 | - | - | 0.89 | 0.00 | -17.70% | -17.20% |
| Corbus Pharmaceuticals Holdings, Inc. | 51,400,000 | -44,000,000 | 1,500,000 | 0.00 | 0.61 | 0.79 | - | - | 0.48 | 0.24 | -60.40% | -36.50% |
| Caribou Biosciences, Inc. | 721,750,000 | 0 | 8,020,000 | 0.00 | 1.22 | 6.46 | - | - | 1.66 | 0.00 | - | - |
| CohBar, Inc. | 26,930,000 | -17,400,000 | 0 | 0.00 | 1.32 | 0.16 | - | - | 1.80 | 0.03 | -115.40% | -96.60% |
| Diffusion Pharmaceuticals Inc. | 28,650,000 | -24,700,000 | 0 | 0.00 | 0.74 | 0.38 | - | - | 0.71 | 0.00 | -59.20% | -55.60% |
| DICE Therapeutics, Inc. | 667,030,000 | 0 | 1,310,000 | 0.00 | 1.94 | 8.37 | - | - | 1.99 | 0.01 | - | - |
| Dermata Therapeutics, Inc. | 11,800,000 | -5,700,000 | 0 | 0.00 | 0.76 | 1.22 | - | - | 0.94 | 0.00 | - | - |
| Eloxx Pharmaceuticals, Inc. | 41,200,000 | -60,800,000 | 0 | 0.00 | 1.22 | 0.00 | - | - | 0.00 | 0.36 | -280.60% | -149.30% |
| Eliem Therapeutics, Inc. | 254,360,000 | -57,300,000 | 0 | 0.00 | 0.75 | 4.88 | - | - | 1.74 | 0.00 | - | - |
| Enveric Biosciences, Inc. | 20,670,000 | -11,300,000 | 0 | 0.00 | 0.14 | 0.35 | - | - | 0.97 | 0.00 | - | - |
| Evofem Biosciences, Inc. | 68,150,000 | -194,200,000 | 4,800,000 | 0.00 | 0.00 | 0.00 | - | - | 0.00 | 0.00 | - | -204.70% |
| Exscientia plc | 2,550,000,000 | 0 | 27,170,000 | 0.00 | 0.01 | 0.00 | - | - | 0.00 | 0.00 | - | - |
| Genenta Science S.p.A. | 155,690,000 | -8,199,999 | 0 | 0.00 | 11.27 | 0.68 | - | - | 12.87 | 0.00 | - | - |
| HCW Biologics Inc. | 81,500,000 | -8,100,000 | 4,099,999 | 0.00 | 1.57 | 1.17 | - | - | 2.03 | 0.00 | - | - |
| Hoth Therapeutics, Inc. | 14,110,000 | -11,600,000 | 0 | 0.00 | 1.05 | 0.60 | - | - | 0.98 | 0.00 | -85.00% | -78.00% |
| Histogen Inc. | 12,670,000 | -15,300,000 | 1,500,000 | 0.00 | 0.47 | 0.36 | - | - | 0.66 | 0.00 | -80.00% | -60.00% |
| iBio, Inc. | 84,930,000 | -24,900,000 | 2,200,000 | 0.00 | 0.81 | 0.36 | - | - | 1.03 | 0.32 | -23.60% | -17.20% |
| Icosavax, Inc. | 685,170,000 | 0 | 7,350,000 | 0.00 | 2.21 | 7.04 | - | - | 2.35 | 0.00 | - | - |
| Idera Pharmaceuticals, Inc. | 27,800,000 | 25,500,000 | 0 | 0.00 | 0.83 | 0.00 | - | - | 0.00 | 0.00 | 466.60% | 58.60% |
| Immix Biopharma, Inc. | 33,080,000 | -2,100,000 | 0 | 0.00 | 0.00 | 0.01 | - | - | 330.85 | 0.00 | - | - |
| Immuron Limited | 18,580,000 | 0 | 150,000 | 0.00 | 0.72 | 0.00 | - | - | 0.00 | 0.00 | - | - |
| Immuneering Corporation | 250,610,000 | 0 | 2,560,000 | 0.00 | 1.10 | 5.67 | - | - | 1.68 | 0.00 | - | - |
| IN8bio, Inc. | 76,010,000 | -11,900,000 | 0 | 0.00 | 1.83 | 2.24 | - | - | 1.87 | 0.02 | 355.50% | -44.80% |
| Indaptus Therapeutics, Inc. | 44,320,000 | -8,100,000 | 0 | 0.00 | 0.53 | 0.00 | - | - | 0.00 | 0.00 | -44.80% | -34.10% |
| MiNK Therapeutics, Inc. | 98,490,000 | 0 | 0 | 0.00 | 0.00 | 0.02 | - | - | 123.11 | 0.00 | - | - |
| IO Biotech, Inc. | 239,700,000 | -59,400,000 | 0 | 0.00 | 0.00 | 1.63 | - | - | 5.27 | 0.00 | - | - |
| Iterum Therapeutics plc | 77,360,000 | -98,600,000 | 0 | 0.00 | 1.41 | 0.47 | - | - | 0.88 | 0.53 | -489.20% | -111.90% |
| Jaguar Health, Inc. | 35,600,000 | -49,600,000 | 4,800,000 | 0.00 | 1.43 | 0.23 | - | - | 2.87 | 1.24 | -193.90% | -82.60% |
| Kala Pharmaceuticals, Inc. | 49,900,000 | -126,100,000 | 11,600,000 | 0.00 | 0.76 | 1.78 | - | - | 0.40 | 1.28 | -141.90% | -58.60% |
| Kiora Pharmaceuticals, Inc. | 9,390,000 | -10,400,000 | 10,000 | 0.00 | 0.42 | 0.84 | - | - | 0.85 | 0.00 | -87.90% | -52.60% |
| Kintara Therapeutics, Inc. | 22,290,000 | -27,200,000 | 0 | 0.00 | 14.99 | 0.28 | - | - | 1.58 | 0.00 | - | -152.90% |
| Pasithea Therapeutics Corp. | 26,490,000 | 0 | 0 | 0.00 | 0.98 | 0.96 | - | - | 1.29 | 0.00 | - | - |
| LianBio | 405,400,000 | 0 | 0 | 0.00 | 0.00 | 1.04 | - | - | 3.72 | 0.00 | - | - |
| Lipocine Inc. | 97,100,000 | -17,800,000 | 50,000 | 0.00 | 2.89 | 0.43 | - | - | 2.52 | 0.09 | -56.30% | -43.50% |
| Stealth BioTherapeutics Corp | 36,500,000 | -50,700,000 | 0 | 0.00 | 0.00 | 0.72 | - | - | 0.86 | 0.00 | 261.50% | -138.00% |
| Marker Therapeutics, Inc. | 48,800,000 | -40,600,000 | 0 | 0.00 | 0.89 | 0.56 | - | - | 1.00 | 0.00 | -75.40% | -56.70% |
| Metacrine, Inc. | 12,790,000 | -59,500,000 | 0 | 0.00 | 0.26 | 2.24 | - | - | 0.21 | 0.20 | -86.10% | -68.80% |
| Matinas BioPharma Holdings, Inc. | 153,820,000 | -23,500,000 | 100,000 | 0.00 | 2.59 | 0.24 | - | - | 2.86 | 0.00 | -38.60% | -33.60% |
| Nabriva Therapeutics plc | 29,200,000 | -54,200,000 | 22,100,000 | 0.00 | 0.40 | 0.88 | - | - | 0.56 | 0.13 | -98.30% | -67.30% |
| NovaBay Pharmaceuticals, Inc. | 14,500,000 | -7,400,000 | 7,700,000 | 0.00 | 1.51 | 0.20 | - | - | 1.61 | 0.00 | -67.60% | -53.80% |
| Minerva Neurosciences, Inc. | 32,500,000 | -35,900,000 | 0 | 0.00 | 1.10 | 0.00 | - | - | 0.00 | 0.00 | -88.50% | -38.60% |
| 9 Meters Biopharma, Inc. | 175,120,000 | -32,200,000 | 0 | 0.00 | 3.66 | 0.21 | - | - | 3.27 | 0.00 | -73.70% | -63.70% |
| NeuroSense Therapeutics Ltd. | 19,610,000 | -5,300,000 | 0 | 0.00 | 10.93 | 0.09 | - | - | 19.61 | 0.00 | - | - |
| Nutriband Inc. | 0 | 0 | 1,390,000 | 0.00 | 0.00 | 0.00 | - | - | 0.00 | 0.00 | - | - |
| Nuvalent, Inc. | 840,060,000 | 0 | 0 | 0.00 | 1.91 | 6.46 | - | - | 2.78 | 0.00 | - | - |
| InVivo Therapeutics Holdings Corp. | 12,410,000 | -9,200,000 | 0 | 0.00 | 0.55 | 0.57 | - | - | 0.59 | 0.00 | -41.30% | -37.10% |
| Oragenics, Inc. | 48,990,000 | -17,800,000 | 0 | 0.00 | 1.83 | 0.25 | - | - | 1.64 | 0.02 | -72.00% | -58.30% |
| Omega Therapeutics, Inc. | 620,100,000 | -56,900,000 | 0 | 0.00 | 1.91 | 4.92 | - | - | 2.65 | 0.05 | - | - |
| OncoSec Medical Incorporated | 37,100,000 | -41,800,000 | 0 | 0.00 | 1.29 | 0.91 | - | - | 1.04 | 0.03 | -102.80% | -70.90% |
| Phio Pharmaceuticals Corp. | 13,010,000 | -12,300,000 | 0 | 0.00 | 0.48 | 1.83 | - | - | 0.49 | 0.00 | -49.90% | -45.00% |
| Protalix BioTherapeutics, Inc. | 42,140,000 | 0 | 49,300,000 | 0.00 | 185.00 | 0.00 | - | - | 0.00 | 0.00 | - | - |
| Plus Therapeutics, Inc. | 22,900,000 | -12,800,000 | 0 | 0.00 | 0.93 | 0.96 | - | - | 1.07 | 0.46 | -130.80% | -67.50% |
| PolarityTE, Inc. | 40,000,000 | -31,700,000 | 12,000,000 | 0.00 | 1.42 | 0.00 | - | - | 0.00 | 0.04 | -115.90% | -65.90% |
| Palatin Technologies, Inc. | 97,650,000 | -36,800,000 | 300,000 | 0.00 | 2.23 | 0.22 | - | - | 1.83 | 0.00 | -65.90% | -49.90% |
| Pulmatrix, Inc. | 20,190,000 | -19,000,000 | 6,700,000 | 0.00 | 0.44 | 0.94 | - | - | 0.38 | 0.00 | -42.80% | -33.20% |
| Pyxis Oncology, Inc. | 262,089,999 | 0 | 0 | 0.00 | 0.00 | 3.84 | - | - | 1.96 | 0.00 | - | - |
| Rani Therapeutics Holdings, Inc. | 833,580,000 | -8,900,000 | 2,900,000 | 0.00 | 15.71 | 2.57 | - | - | 6.43 | 0.00 | - | - |
| Regulus Therapeutics Inc. | 22,110,000 | -22,000,000 | 5,000,000 | 0.00 | 0.76 | 0.40 | - | - | 0.62 | 0.16 | -74.00% | -51.80% |
| Rallybio Corporation | 440,190,000 | 0 | 0 | 0.00 | 2.06 | 5.92 | - | - | 2.35 | 0.00 | - | - |
| RenovoRx, Inc. | 32,210,000 | 0 | 0 | 0.00 | 1.18 | 2.03 | - | - | 1.82 | 0.00 | - | - |
| Roivant Sciences Ltd. | 5,030,000,000 | -1,061,300,000 | 42,600,000 | 0.00 | 2.19 | 3.40 | - | - | 2.01 | 0.10 | - | - |
| Sesen Bio, Inc. | 140,120,000 | -24,300,000 | 6,500,000 | 0.00 | 0.85 | 0.87 | - | - | 0.80 | 0.00 | -46.20% | -12.40% |
| Salarius Pharmaceuticals, Inc. | 22,100,000 | -10,800,000 | 3,300,000 | 0.00 | 0.49 | 0.68 | - | - | 0.69 | 0.00 | -27.20% | -25.90% |
| Soligenix, Inc. | 26,300,000 | -13,400,000 | 900,000 | 0.00 | 1.70 | 0.69 | - | - | 0.91 | 0.65 | -103.60% | -48.30% |
| Sonnet BioTherapeutics Holdings, Inc. | 18,480,000 | -25,000,000 | 500,000 | 0.00 | 1.10 | 0.31 | - | - | 0.95 | 0.00 | -240.80% | -156.90% |
| Surrozen, Inc. | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | - | - | 0.00 | 0.00 | - | - |
| Synthetic Biologics, Inc. | 34,610,000 | -21,000,000 | 0 | 0.00 | 0.47 | 0.55 | - | - | 0.48 | 0.00 | -37.80% | -35.00% |
| Tenax Therapeutics, Inc. | 17,700,000 | -32,100,000 | 0 | 0.00 | 2.21 | 0.30 | - | - | 2.11 | 0.00 | -781.30% | -552.70% |
| Theseus Pharmaceuticals, Inc. | 414,850,000 | 0 | 0 | 0.00 | 0.00 | 2.33 | - | - | 4.59 | 0.00 | - | - |
| Tiziana Life Sciences PLC | 15,400,000 | -39,300,000 | -3,600,000 | 0.00 | 2.31 | 2.51 | - | - | 0.29 | 0.02 | -141.90% | -109.40% |
| Timber Pharmaceuticals, Inc. | 23,320,000 | -7,200,000 | 800,000 | 0.00 | 0.00 | 0.05 | - | - | 6.86 | 0.00 | -178.20% | -85.40% |
| Tonix Pharmaceuticals Holding Corp. | 109,140,000 | -79,800,000 | 0 | 0.00 | 0.38 | 0.35 | - | - | 0.60 | 0.00 | -49.30% | -46.50% |
| Tenaya Therapeutics, Inc. | 598,200,000 | -56,900,000 | 0 | 0.00 | 1.32 | 7.01 | - | - | 2.13 | 0.00 | - | - |
| Entrada Therapeutics, Inc. | 313,220,000 | 0 | 0 | 0.00 | 0.00 | 4.42 | - | - | 2.56 | 0.00 | - | - |
| Trevi Therapeutics, Inc. | 13,600,000 | -34,900,000 | 0 | 0.00 | 0.96 | 1.10 | - | - | 0.46 | 1.27 | -174.50% | -87.00% |
| Trevena, Inc. | 80,230,000 | -49,500,000 | 600,000 | 0.00 | 1.03 | 0.00 | - | - | 0.00 | 0.00 | -53.50% | -44.00% |
| Tyme Technologies, Inc. | 60,650,000 | -24,800,000 | 0 | 0.00 | 0.67 | 0.42 | - | - | 0.81 | 0.00 | -25.50% | -23.70% |
| Tyra Biosciences, Inc. | 508,050,000 | -20,000,000 | 0 | 0.00 | 1.56 | 7.55 | - | - | 1.62 | 0.00 | - | - |
| Vaxxinity, Inc. | 800,900,000 | 0 | 70,000 | 0.00 | 0.00 | 0.69 | - | - | 8.96 | 0.00 | - | - |
| vTv Therapeutics Inc. | 65,400,000 | -4,800,000 | 10,400,000 | 0.00 | 0.00 | 0.21 | - | - | 3.34 | 0.00 | 9.40% | -22.70% |
| Ventyx Biosciences, Inc. | 617,110,000 | -84,200,000 | 0 | 0.00 | 0.00 | 2.77 | - | - | 4.35 | 0.00 | - | - |
| VYNE Therapeutics Inc. | 30,290,000 | -84,900,000 | 16,700,000 | 0.00 | 0.45 | 0.00 | - | - | 0.00 | 0.00 | -128.60% | -74.10% |
| Exicure, Inc. | 16,520,000 | -63,000,000 | -2,460,000 | 0.00 | 1.09 | 0.64 | - | - | 0.27 | 0.00 | -155.30% | -73.90% |
| Xilio Therapeutics, Inc. | 342,850,000 | 0 | 0 | 0.00 | 0.00 | 3.88 | - | - | 3.44 | 0.00 | - | - |
| XOMA Corporation | 0 | 0 | 29,800,000 | 306.95 | 2.55 | 0.00 | 2.09 | 8.30% | 0.00 | 0.00 | - | - |
| Zosano Pharma Corporation | 39,210,000 | -31,100,000 | 900,000 | 0.00 | 0.67 | 0.10 | - | - | 2.29 | 0.15 | -72.20% | -49.00% |